1636P Health-related quality of life outcomes of androgen receptor pathway inhibitors versus taxanes versus standard of care in metastatic castration-resistant prostate cancer: Results from the ProBio trial
| Autor: | Bultijnck, R., Strijbos, M.H., Mortezavi, A., Lindberg, J., Discacciati, A., Karlsson, C.T., Ullén, A., Jänes, E., Enblad, G., Oldenburg, J., Sautois, B., Hjälm-Eriksson, M.E., Sagstuen Haugnes, H., Schatteman, P., Ghysel, C., De Laere, B., Eklund, M., Grönberg, H., Ost, P., Crippa, A. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S987-S987 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|